Topical tacrolimus: A novel therapeutic intervention for recalcitrant labial pemphigus vulgaris

European Journal of Dermatology

Volumn 13, Issue 2, 2003, Pages 142-144

  Hodgson, Tim A ^a   Malik, Forhana ^a   Hegarty, Anne M ^a   Porter, Stephen R ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Lip; Mucosal; Pemphigus vulgaris; Tacrolimus; Ulceration

Indexed keywords

AZATHIOPRINE; BECLOMETASONE; BENZYDAMINE; CLOBETASOL PROPIONATE; CORTICOSTEROID; CYCLOSPORIN; DAPSONE; FLUTICASONE PROPIONATE; IMMUNOGLOBULIN G; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; TRIAMCINOLONE ACETONIDE;

ADULT; ANTIBODY TITER; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; CUSHINGOID SYNDROME; DISEASE CONTROL; DISEASE EXACERBATION; DRUG FORMULATION; DRUG INDUCED DISEASE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIP; MAXIMUM TOLERATED DOSE; METERED DOSE INHALER; MOOD DISORDER; PEMPHIGUS VULGARIS; REMISSION; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; ULCER HEALING;

ADMINISTRATION, TOPICAL; ADULT; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIP; MOUTH DISEASES; PEMPHIGUS; RECURRENCE; TACROLIMUS; TREATMENT OUTCOME; ULCER;

EID: 0037358030     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Toth GG, Jonkman MF. Therapy for pemphigus. Clin Dermatol 2001; 19: 761-7.
2. Korman NJ. New immunomodulating drugs in autoimmune blistering diseases. Dermatol Clin 2001; 19: 637-48, viii.
3. Nasr IS. Topical tacrolimus in dermatology. Clin Exp Derm 2000; 25: 250-4.
4. Gupta AK, Adamiak A, Chow M. Tacrolimus: a review of its use for the management of dermatoses. JEADV 2002; 16: 100-14.
5. Ayoama H, Tabata N, Tanaka M, Uesugi Y, Tagami H. Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK506 ointment. British Journal of Dermatology 1995; 133: 492-500.
6. Alaiti S, Kang S, Fielder VC, Ellis CN, Spurlin DV, Fader D. Tacrolimus (FK506) ointment for atopic dermatitis: a phase I study in adults and children. J Am Acad Dermatol 1998; 38: 69-76.
7. Reitamo S, Wollenberg A, Schopf E, Perrot JL, Marks R, Ruzicka T et al. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group. Arch Dermatol 2000; 136: 999-1006.
8. Alak AM, Moy S, Cook M, Lizak P, Niggebiugge A, Menard S et al. An HPLC/MS/MS assay for tacrolimus in patient blood sample with results of an ELISA assay. J Pharm Biomed Anal 1997; 16: 7-13.
9. Nishifuji K, Amagai M, Kuwana M, Iwasaki T, Nishikawa T. Detection of antigen-specific B cells in patients with pemphigus vulgaris by enzyme-linked immunospot assay: requirement of T cell collaboration for autoantibody production. J Invest Dermatol 2000; 114: 88-94.
10. Almawi WY, Assi JW, Chudzik DM, Chudzik DM, Jaoude MM, Rieder MJ. Inhibition of cytokine production and cytokine-stimulated T-cell activation by FK505 (tacrolimus). Cell Transplant 2001; 10: 615-23.
11. Scully C, Paes de Almeida O, Porter SR, Gilkes JJH. Pemphigus vulgaris: the manifestations and long term management of 55 patients with oral lesions. Br J Dermatol 1999; 140: 84-9.
12. Mignogna MD, Lo Muzio L, Mignogna RE, Carbone R, Ruoppo E, Bucci E. Oral pemphigus: longterm behaviour and clinical response to treatment with Deflazacort in sixteen cases. J Oral Pathol Med 2000; 29: 145-52.
13. Vente C, Reigh K, Rupprecht R and Neumann C. Erosive mucosal lichen planus: response to topical treatment with tacrolimus. Br J Dermatol 1999; 140: 338-4.
14. Lener EV, Brieva J, Schachter M, West LE, West DP, El-Azhary RA. Successful treatment of erosive lichen plonus with topical tocrolimus. Arch Dermatol 2001; 137: 419-22.
15. Kaliakatsou F, Hodgson TA, Lewsey JD, Hegarty AM, Murphy AG, Porter SR. Management of recalcitrant ulcerative oral lichen planus with topical tacrolimus. J Am Acad Dermatol 2002; 46: 35-41.
16. Rozycki TW, Rogers RS 3rd, Pittelkow MR, McEvoy MT, El-Azhary RA, Bruce AJ et al. Topical tacrolimus in the treatment of symptomatic oral lichen planus: a series of 13 patients. J Am Acad Dermatol 2002; 46: 27-34.
17. Nazzaro G, Cestari R. Topical tacrolimus ointment in ulcerative lichen planus: an alternative therapeutic approach. Eur J Dermatol 2002; 12: 321.
18. Olivier V, Lacour JP, Mousnier A, Garraffo R, Monteil RA, Ortonne JP. Treatment of chronic erosive oral lichen planus with low concentrations of topical tacrolimus: an open prospective study. Arch Dermatol 2002; 138: 1335-8.
19. rd, Gorman A. An open trial of tacrolimus for erosive oral lichen planus. J Am Acad Dermatol 2002; 47: 617-20.
20. Russell R, Richardson N, Wilson DC. Systemic absorption with complications during topical tacrolimus treatment for orofacial crohn disease. J Pediatr Gastroenterol and Nutr 2001; 32: 207-8.
21. Hodgson TA, Hegarty AM, Porter SR. Topical tacrolimus for oral crohn disease. J Pediatr Gastroenterol Nutr 2001; 33: 633. Letter.
22. Rabeni EJ, Cunningham NM. Effective treatment of Hailey-Hailey disease with topical tacrolimus. J Am Acad Dermatol 2002; 47: 797-8. Letter.